Dimenhydrinate

Specifications

523-87-5CAS Number

208-350-8EC Number

2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dioneIUPAC Name

C24H28ClN5O3Chemical Formula

470 g/molMolecular Weight

DIMENHYDRINATE; 523-87-5; Dramamine; Travelin; Diphenhydrinate; Vomex A; Anautine; Amosyt; Chloranautine; Aviomarin; Gravol; Menhydrinate; Andramine; Diamarin; Dramamin; Dramarin; Permital; Supremal; Teodramin; Xamamina; Antemin; Dramyl; Dromyl; Reise-Engletten; Neo-Navigan; Diphenhydramine Theoclate; Dimenhidrinato; Reidamine; Removine; Emedyl; Faston; DTXSID9025087; Dimenhydrinatum; Dimenidrinato; 2-(Diphenylmethoxy)-N,N-dimethylethylamine 8-chlorotheophyllinate; Diphenhydramine 8-chlorotheophylline; JB937PER5C; Diphenhydramine 8-chlorotheophyllinate; NCI-C60639; O-Benzhydryldimethylaminoethanol 8-chlorotheophyllinate; DTXCID705087; (o-Benzhydryl(dimethylamino)ethanol) 8-chlorotheophyllinate; Benzhydryl-beta-dimethylaminoethylether 8-chlorotheophylline; N,N-Dimethyl-2-diphenylmethoxyethylamine 8-chlorotheophyllinate; beta-Dimethylaminoethyl benzhydryl ether 1,3-dimethyl-8-chloroxanthine; NSC117855; 2-(Benzhydryloxy)-N,N-dimethylethylamine 8-chlorotheophyllinate; Ethylamine 2-(diphenylmethoxy)-N,N-dimethyl-, compd with 8-chlorotheophylline (1:1); Theophylline, 8-chloro-, compd with 2-(diphenylmethoxy)-N,N-dimethyethylamine (1:1); Vertigo Vomex; Motion Aid; Heumann, Dimen; Apo Dimenhydrinate; Calm X; Lichtenstein, Dimen; Stada, Reisetabletten; Reisetabletten ratiopharm; Theoclate, Diphenhydramine; [o-Benzhydryl(dimethylamino)ethanol] 8-chlorotheophyllinate; Driminate; Motion Sickness; Vertigo-vomex s; Airmit Ace; Dramamine Orange; Wal-dram; Dramamine for Kids; 8-chloro-1,3-dimethyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione; (2-(diphenylmethoxy)ethyl)dimethylamine; 8-chloro-1,3-dimethyl-2,3,6,9-tetrahydro-1H-purine-2,6-dione; [2-(diphenylmethoxy)ethyl]dimethylamine; Dimenhydrinate 50mg; Motion Sickness Relief; RefChem:5758; Dramamine Original Formula; Dramamine, TRAVEL BASIX; Gravol Chewables Motion Sickness Dimenhydrinate; Kids Gravol Chewables Motion Sickness Dimenhydrinate; 2-(Diphenylmethoxy)-N,N-dimethylethylamine-8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione (1/1); 208-350-8; 8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione-2-(diphenylmethoxy)-N,N-dimethylethanamine (1:1); CHEBI:4604; Dimenest; Dimentabs; Dramalen; Dramilin; Eldodram; Gravinol; Hydrinate; Novamine; Travelmin; Troversin; Dimate; MFCD00054265; NSC 117855; NSC-117855; 8-Chlorotheophylline, compound with 2-(diphenylmethoxy)-N,N-dimethylethylamine (1:1); 8-Chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione 2-(benzhydryloxy)-N,N-dimethylethanamine salt; 8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dione compound with 2-(benzhydryloxy)-N,N-dimethylethanamine (1:1); Theohydramine; Dommanate; Lomarin; 2-benzhydryloxy-N,N-dimethylethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione; C24H28ClN5O3; Novamin (VAN); Gravinol (antiemetic); Dimenidrinato [DCIT]; SR-05000001608; Dimenhydrinat; Dimenhydrinatum [INN-Latin]; Dimenhidrinato [INN-Spanish]; CCRIS 4798; HSDB 3064; Am osyt; Dimenhydrinate CRS; Dramamine (TN); EINECS 208-350-8; Spectrum_000974; Prestwick3_000265; Spectrum2_000992; Spectrum3_000397; Spectrum4_000517; Spectrum5_000909; Dimenhydrinate (Standard); UNII-JB937PER5C; DIMENHYDRINATE [MI]; SCHEMBL5128; DIMENHYDRINATE [INN]; DIMENHYDRINATE [JAN]; BSPBio_000110; BSPBio_002213; DIMENHYDRINATE [HSDB]; KBioGR_001093; KBioSS_001454; DIMENHYDRINATE [VANDF]; DivK1c_000049; SPECTRUM1500251; SPBio_001083; DIMENHYDRINATE [MART.]; BPBio1_000122; orb1224806; orb1310746; DIMENHYDRINATE [USP-RS]; DIMENHYDRINATE [WHO-DD]; CHEMBL1200406; CHEBI:94848; HMS500C11; HY-B1215R; KBio1_000049; KBio2_001454; KBio2_004022; KBio2_006590; KBio3_001433; Dimenhydrinate (JP18/USP/INN); NINDS_000049; HMS1920G20; HMS2091O08; HMS2095F12; HMS3712F12; HMS5083M12; Pharmakon1600-01500251; Dimenhydrinate - Bio-X trade mark; HY-B1215; DIMENHYDRINATE [EP IMPURITY]; DIMENHYDRINATE [ORANGE BOOK]; Dimenhydrinate [USP:INN:BAN:JAN]; Tox21_200323; CCG-40210; DIMENHYDRINATE [EP MONOGRAPH]; EBC-27174; EBC-47504; NSC756740; s4672; DIMENHYDRINATE [USP MONOGRAPH]; AKOS015896341; AC-8241; CS-4841; DB00985; FD22159; NSC-756740; IDI1_000049; NCGC00021154-01; NCGC00021154-02; NCGC00021154-03; NCGC00021154-04; NCGC00021154-05; NCGC00021154-06; NCGC00021154-07; NCGC00021154-09; NCGC00091928-01; NCGC00091928-02; NCGC00091928-03; NCGC00257877-01; AS-13166; BD166163; Dimenhydrinate for peak identification CRS; SBI-0051350.P003; AB00053833; NS00076452; D00520; D82297; WLN: T56 BM DN FNVNVJ CG F H &622; EN300-37158633; Q420439; SR-05000001608-1; SR-05000001608-2; BRD-M98649031-001-01-1; BRD-M98649031-001-08-6; BRD-M98649031-001-09-4; 8-Chlorotheophylline 2-(diphenylmethoxy)-N,N-dimethylethylamine; Dimenhydrinate, European Pharmacopoeia (EP) Reference Standard; Dimenhydrinate, United States Pharmacopeia (USP) Reference Standard; 2-benzhydryloxy-N,N-dimethyl-ethanamine;8-chloro-1,3-dimethyl-7H-purine-2,6-dione; Dimenhydrinate for peak identification, European Pharmacopoeia (EP) Reference Standard; Dimenhydrinate, Pharmaceutical Secondary Standard; Certified Reference Material; 8-chloro-1,3-dimethyl-1H-purine-2,6(3H,7H)-dionecompoundwith2-(benzhydryloxy)-N,N-dimethylethanamine(1:1); 8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione compound with 2-(benzhydryloxy)-N,N-dimethylethan-1-amine (1:1); 8-chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione--2-(benzhydryloxy)-N,N-dimethylethan-1-amine (1/1); 8-Chloro-1,3-dimethyl-3,7-dihydro-1H-purine-2,6-dione--2-(diphenylmethoxy)-N,N-dimethylethan-1-amine (1/1)Synonyms